BNP Paribas Financial Markets’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-152,809
| Closed | -$892K | – | 5739 |
|
|
2025
Q1 | $892K | Buy |
152,809
+62,028
| +68% | +$327K | ﹤0.01% | 2871 |
|
|
2024
Q4 | $338K | Sell |
90,781
-44,364
| -33% | -$205K | ﹤0.01% | 3549 |
|
|
2024
Q3 | $755K | Buy |
135,145
+85,324
| +171% | +$597K | ﹤0.01% | 2652 |
|
|
2024
Q2 | $419K | Sell |
49,821
-1,776
| -3% | -$18.9K | ﹤0.01% | 2755 |
|
|
2024
Q1 | $745K | Buy |
51,597
+33,760
| +189% | +$558K | ﹤0.01% | 2643 |
|
|
2023
Q4 | $384K | Sell |
17,837
-3,971
| -18% | -$70.9K | ﹤0.01% | 2941 |
|
|
2023
Q3 | $419K | Sell |
21,808
-8,935
| -29% | -$191K | ﹤0.01% | 2816 |
|
|
2023
Q2 | $781K | Sell |
30,743
-43,883
| -59% | -$1.27M | ﹤0.01% | 2342 |
|
|
2023
Q1 | $2.7M | Sell |
74,626
-26,203
| -26% | -$920K | ﹤0.01% | 1625 |
|
|
2022
Q4 | $3.99M | Buy |
+100,829
| New | +$4.19M | 0.01% | 1423 |
|
|
2022
Q3 | – | Sell |
-46,343
| Closed | -$2.03M | – | 5065 |
|
|
2022
Q2 | $2.03M | Buy |
46,343
+8,532
| +23% | +$469K | ﹤0.01% | 1747 |
|
|
2022
Q1 | $2.73M | Buy |
37,811
+30,213
| +398% | +$2.18M | ﹤0.01% | 1622 |
|
|
2021
Q4 | $616K | Buy |
7,598
+581
| +8% | +$58.2K | ﹤0.01% | 2902 |
|
|
2021
Q3 | $817K | Buy |
7,017
+1,108
| +19% | +$145K | ﹤0.01% | 2490 |
|
|
2021
Q2 | $980K | Buy |
5,909
+390
| +7% | +$60.9K | ﹤0.01% | 2194 |
|
|
2021
Q1 | $770K | Sell |
5,519
-834
| -13% | -$136K | ﹤0.01% | 2304 |
|
|
2020
Q4 | $1.1M | Sell |
6,353
-1,619
| -20% | -$262K | ﹤0.01% | 1964 |
|
|
2020
Q3 | $1.11M | Buy |
7,972
+5,866
| +279% | +$784K | ﹤0.01% | 1760 |
|
|
2020
Q2 | $252K | Sell |
2,106
-7,837
| -79% | -$930K | ﹤0.01% | 2400 |
|
|
2020
Q1 | $994K | Sell |
9,943
-14,050
| -59% | -$1.69M | ﹤0.01% | 1909 |
|
|
2019
Q4 | $2.82M | Buy |
23,993
+18,655
| +349% | +$1.85M | 0.01% | 1513 |
|
|
2019
Q3 | $459K | Buy |
5,338
+1,288
| +32% | +$97.5K | ﹤0.01% | 2264 |
|
|
2019
Q2 | $263K | Sell |
4,050
-2,647
| -40% | -$165K | ﹤0.01% | 2436 |
|
|
2019
Q1 | $419K | Buy |
6,697
+6,028
| +901% | +$283K | ﹤0.01% | 2208 |
|
|
2018
Q4 | $26K | Sell |
669
-984
| -60% | -$43.7K | ﹤0.01% | 3006 |
|
|
2018
Q3 | $94.2K | Buy |
1,653
+64
| +4% | +$4K | ﹤0.01% | 2769 |
|
|
2018
Q2 | $127K | Sell |
1,589
-4,366
| -73% | -$362K | ﹤0.01% | 2666 |
|
|
2018
Q1 | $516K | Buy |
5,955
+234
| +4% | +$18.9K | ﹤0.01% | 2191 |
|
|
2017
Q4 | $395K | Buy |
5,721
+2,497
| +77% | +$200K | ﹤0.01% | 2608 |
|
|
2017
Q3 | $293K | Sell |
3,224
-254
| -7% | -$21.7K | ﹤0.01% | 2264 |
|
|
2017
Q2 | $259K | Buy |
3,478
+2,969
| +583% | +$238K | ﹤0.01% | 2292 |
|
|
2017
Q1 | $47.7K | Sell |
509
-1,259
| -71% | -$114K | ﹤0.01% | 2755 |
|
|
2016
Q4 | $128K | Sell |
1,768
-209
| -11% | -$17.9K | ﹤0.01% | 2422 |
|
|
2016
Q3 | $206K | Buy |
1,977
+1,039
| +111% | +$93.8K | ﹤0.01% | 1729 |
|
|
2016
Q2 | $69.2K | Buy |
+938
| New | +$63.7K | ﹤0.01% | 2225 |
|
|
2016
Q1 | – | Sell |
-3,266
| Closed | -$220K | – | 3118 |
|
|
2015
Q4 | $220K | Sell |
3,266
-125
| -4% | -$6.69K | ﹤0.01% | 1873 |
|
|
2015
Q3 | $157K | Buy |
3,391
+2,129
| +169% | +$103K | ﹤0.01% | 2114 |
|
|
2015
Q2 | $67.8K | Buy |
1,262
+1,077
| +582% | +$54.9K | ﹤0.01% | 2308 |
|
|
2015
Q1 | $8.87K | Buy |
+185
| New | +$8.03K | ﹤0.01% | 2825 |
|
Other funds holding NVRO
BNP Paribas Financial Markets's NVRO Position: Q2 2025 in Review
BNP Paribas Financial Markets sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 152,809 shares — an estimated $892K sold.
BNP Paribas Financial Markets first reported a position in NVRO in Q1 2015 and held it in 39 quarters. The position peaked at $3.99M in Q4 2022. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- BNP Paribas Financial Markets reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 152,809 NEVRO CORP. shares in Q2 2025, an estimated $892K.
- BNP Paribas Financial Markets first reported a position in NEVRO CORP. in Q1 2015 and held it in 39 quarters.
- BNP Paribas Financial Markets's NEVRO CORP. position peaked at $3.99M in Q4 2022.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.